Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients
Year: 2017
Type: article
Study design: Observational Study
Source: Medical Oncology
Authors: Dilsa Mizrak Kaya, Xiaochuan Dong, Graciela M. Nogueras-González, Yan Xu, Jeannelyn S. Estrella, Kazuto Harada, Anthony Lopez, Fatemeh G. Amlashi, Wayne L. Hofstetter, Dipen M. Maru, Quynh-Nhu Nguyen, Jeffrey H. Lee, Brian Weston, Manoop S. Bhutani, Jeremy J. Erasmus, Irene Thomas, Jane E. Rogers, Shumei Song, Jaffer A. Ajani
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: U.S. Department of Defense
OpenAlex ID: W2734004514